SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes: Systematic Review
16 references·2 citing·42 second hop
Cost-Effectiveness of Therapeutic Education to Prevent the Development and Progression of Type 2 Diabetes: Systematic Review (2014)Cost-Effectiveness of Therapeutic Educati…The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention (2012)The 10-Year Cost-Effectivenes…Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)Modeling Good Research Practi…Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases (2010)Economic Evaluation of Lifest…Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis (2010)Delivering the diabetes educa…Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)Cost-Effectiveness of Interve…Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet (2009)Cost-Effectiveness of a Telep…Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial (2008)Cost effectiveness of self mo…Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective (2007)Lifestyle intervention to pre…The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)The Cost-Effectiveness of Lif…Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria (2005)Criteria list for assessment …Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Clinical Outcomes and Cost-Ef…Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom (2004)Intensive lifestyle changes o…Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)Within-Trial Cost-Effectivene…Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Principles of Good Practice f…Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-effectiveness of Intensi…Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Model of Complications of NID…A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies (2023)A consensus-based checklist f…A systematic review of economic evaluations of treatments for patients with epilepsy (2017)A systematic review of econom…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)The Cost of Diabetes Care—An Elephant in the Room (2018)Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review (2020)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Proceedings of the 2004 Winter Simulation Conference, 2004. (2004)Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions (2011)Valuing Health-Related Quality of Life in Diabetes (2002)Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis (2008)Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis (2010)The Lifetime Cost of Diabetes and Its Implications for Diabetes Prevention (2014)Department of Labor (1941)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Economic Costs of Diabetes in the U.S. in 2002 (2003)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study (2010)The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes (2010)2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group (2015)Assessing Quality in Decision Analytic Cost-Effectiveness Models (2000)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Economic Evaluation in Health Care: Merging Theory with Practice (2002)Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis (2007)Model Transparency and Validation (2012)Simulation Modeling and Analysis. (1983)Simulation modeling and analysis (1999)Decision Modelling For Health Economic Evaluation (2006)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force (2013)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians (2007)Health Psychology: The Search for Pathways between Behavior and Health (2007)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Systematic review of the use and value of computer simulation modelling in population health and health care delivery (2003)Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments (2007)
this work references cited by second hop

References

  • 2003Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies1,181 cited
  • 2005Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria858 cited
  • 2012Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1767 cited
  • 2005The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance703 cited
  • 2002Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes507 cited
  • 2010Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review491 cited
  • 2012The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention435 cited
  • 1997Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia333 cited
  • 2005Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes318 cited
  • 2003Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes262 cited
  • 2010Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis251 cited
  • 2008Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

206 cited
  • 2004Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom128 cited
  • 2009Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet115 cited
  • 2010Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases109 cited
  • 2007Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective97 cited
  • Cited by

    • 2023A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies51 cited
    • 2017A systematic review of economic evaluations of treatments for patients with epilepsy49 cited